Medline ® Abstract for Reference 211
of 'Chemotherapy hepatotoxicity and dose modification in patients with liver disease'
A phase I study of hydroxyurea.
THURMAN WG, BLOEDOW C, HOWE CD, LEVIN WC, DAVIS P, LANE M, SULLIVAN MP, GRIFFITH KM
Cancer Chemother Rep. 1963;29:103.